ZM640
ZM640 is a NLRP3 inhibitor. ZM640 enhances IL-1β release mediated by NLRP3 inflammasome activation in THP-1 cells. ZM640 shows low cytotoxicity[1].
Product Specifications
UNSPSC
12352005
Target
NOD-like Receptor (NLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zm640.html
Solubility
10 mM in DMSO
Smiles
O=S(NCC[C@H]1[C@H](CC2)[C@@H](O)[C@@]([C@@]3(O)[C@@H](O)[C@]4([H])C(C)(C)CC5)(C1=O)[C@]2([H])[C@]4(CO3)[C@H]5O)(C6=CC=C(C=C6)C(F)(F)F)=O
Molecular Formula
C28H36F3NO8S
Molecular Weight
603.65
References & Citations
[1]Li M, et al. Discovery of novel oridonin sulfamide derivatives as potent NLRP3 inhibitors by a visible-light photocatalysis-enabled peripheral editing. Bioorg Med Chem Lett. Published online January 18, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1446841-01 0.02 mg (E-Coli)
Recombinant Human Poly [ADP-ribose] polymerase 16 (PARP16), partial
Ask
View Details MBS1446841-02 0.02 mg (Baculovirus)
Recombinant Human Poly [ADP-ribose] polymerase 16 (PARP16), partial
Ask
View Details